Meet us at upcoming industry events to learn how our synthetic DNA solutions can accelerate your research and therapeutic development. Our team will be on hand to discuss your needs, book a meeting or drop by our booth to connect
Where can you meet us?
EVENTS
Personalized Cancer Vaccine Summit
18 - 20 NOV 2025
Boston, MA, USA
We are pleased to share that our Director of Scientific Applications, Emily Young, will be speaking on day 1 at the upcoming Personalized Cancer Vaccines (PCV) Conference, joined by Jennifer Gelman, Head of Marketing.
Talk: Enabling Rapid and Agile Manufacturing Workflows for Personalized Immunotherapies with Synthetic DNA
Time: 11:00 AM, November 20th
Emily will discuss how synthetic, enzymatically produced DNA enables rapid, flexible, and scalable manufacturing for personalized immunotherapies. Her presentation will highlight how 4basebio’s cell-free DNA platform simplifies mRNA-based workflows and supports the development of personalized cancer vaccines, including a collaborative project with Neomatrix.
If you are attending PCV and would like to connect with Emily of Jen to learn how our synthetic DNA is driving innovation in personalized cancer vaccines, click here.
RNA-Based Therapeutics & Vaccines Summit
18 - 20 NOV 2025
Incheon, South Korea
We’re excited to share that James Vang, Senior BD Director, will be presenting at the upcoming RNA-Based Therapeutics & Vaccines Summit in South Korea. This leading event brings together innovators, researchers, and industry experts to discuss the latest advances shaping the future of RNA medicines.
Talk: Synthetic DNA: The New Standard in Scalable GMP-Grade Manufacture for mRNA Therapeutics
Time: 11:50 AM, November 20th
James will discuss how synthetic, enzymatically produced DNA is redefining mRNA manufacture, enabling rapid, scalable GMP-grade production without bacterial contaminants. His talk will explore opDNA®, our open-ended IVT template designed for efficient, flexible, and regulatory-ready mRNA production, supporting everything from large-scale manufacturing to personalized immunotherapies.
If you’re attending the summit and would like to connect with James to learn more about our synthetic DNA solutions, click here to get in touch.